Back to Search
JULIO CORTES, M.D.
M.D.
Internal Medicine Physician
NPI: 1952309700Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
038715(GA)
Research & Publications (20)
Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos.
PMID 19401322·Hum Reprod·2009
7-preclinical
Trends in healthcare utilization for diarrhea and rotavirus disease in privately insured US children <5 years of age, 2001-2006.
PMID 19590460·Pediatr Infect Dis J·2009
8-other
Reproductive medicine meets human embryonic stem cell (hESC) research: the need to adjust the regulatory framework to actual expectations and potential detrimental consequences of hESC research.
PMID 18692797·Fertil Steril·2009
8-other
Whole-blastocyst culture followed by laser drilling technology enhances the efficiency of inner cell mass isolation and embryonic stem cell derivation from good- and poor-quality mouse embryos: new insights for derivation of human embryonic stem cell lines.
PMID 18447641·Stem Cells Dev·2008
7-preclinical
Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3.
PMID 17785825·J Immunol·2007
7-preclinical
Spanish stem cell bank interviews examine the interest of couples in donating surplus human IVF embryos for stem cell research.
PMID 18371329·Cell Stem Cell·2007
8-other
Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cells.
PMID 19508387·J Cell Mol Med·2010
7-preclinical
Azacitidine for the treatment of myelodysplastic syndrome.
PMID 19589026·Expert Rev Anticancer Ther·2009
6-review
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).
PMID 19536906·Cancer·2009
3-trial
Optimizing first-line therapy for patients with chronic myeloid leukemia.
PMID 19621543·Semin Hematol·2009
8-other
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
PMID 19652056·J Clin Oncol·2009
3-trial
Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure.
PMID 19517473·Cancer·2009
3-trial
Island parity. Puerto Rico needs full payments from federal programs.
PMID 19606669·Mod Healthc·2009
8-other
Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance.
PMID 19531657·Blood·2009
8-other
Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial.
PMID 19536894·Cancer·2009
3-trial
Imatinib and beyond--exploring the full potential of targeted therapy for CML.
PMID 19652654·Nat Rev Clin Oncol·2009
6-review
Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase.
PMID 19517462·Cancer·2009
8-other
Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma.
PMID 19665777·J Allergy Clin Immunol·2009
7-preclinical
Chronic myeloid leukemia in the tyrosine kinase inhibitor era: what is the best therapy?
PMID 19679008·Curr Oncol Rep·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1326 EISENHOWER DR, BUILDING 1
SAVANNAH, GA 31406 - Phone
- (912) 691-4100
Quick Facts
- NPI
- 1952309700
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile